A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME

Endocr Pract. 2018 Nov;24(11):963-972. doi: 10.4158/EP-2018-0238. Epub 2018 Aug 14.

Abstract

Objective: The water deprivation test (WDT) is widely used for the differential diagnosis of the polyuria-polydipsia syndrome (PPS). However, it is inconvenient and may not always be precise in differentiating partial forms of diabetes insipidus (DI) from primary polydipsia (PP). The aim of this study was to evaluate the results of a combined outpatient and inpatient overnight WDT protocol that included an overnight unsupervised period concerning its feasibility and safety.

Methods: We performed a retrospective analysis of clinical data and laboratory results of 52 patients with PPS undergoing WDT at a single center.

Results: PP was the most frequent diagnosis, followed by complete central DI (cCDI), partial central DI (pCDI), and nephrogenic DI (NDI). Over 90% of the patients showed an expected increase in serum osmolality at the end of the dehydration period. There were no reports of complications during the overnight deprivation period. Post-dehydration urine osmolality and urine-to-serum osmolality ratio significantly differentiated all the groups ( P<.05), except for cCDI and NDI, which could be differentiated by basal and post-dehydration vasopressin (AVP) levels ( P<.05 for both). Although these measurements were useful for differentiating patients according to their allocation groups, results from WDT and direct AVP levels may often require a comprehensive diagnostic approach, particularly in the challenging groups of PP and pCDI.

Conclusion: A combined outpatient and inpatient overnight WDT protocol is safe and feasible when the test is performed with special care at experienced centers. Newer diagnostic tools are expected to improve the accuracy of PPS diagnosis.

Abbreviations: AQP2 = aquaporin-2; AVP = vasopressin; CDI = central diabetes insipidus; cCDI = complete central diabetes insipidus; DDAVP = desmopressin; DI = diabetes insipidus; IQR = interquartile range; MRI = magnetic resonance imaging; Na+ = sodium; NDI = nephrogenic diabetes insipidus; pCDI = partial central diabetes insipidus; PP = primary polydipsia; PPS = polyuria-polydipsia syndrome; S_osm = serum osmolality; U_osm = urine osmolality; WDT = water deprivation test.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Ambulatory Care*
  • Child
  • Diabetes Insipidus, Nephrogenic / blood
  • Diabetes Insipidus, Nephrogenic / diagnosis*
  • Diabetes Insipidus, Neurogenic / blood
  • Diabetes Insipidus, Neurogenic / diagnosis*
  • Female
  • Hospitalization*
  • Humans
  • Male
  • Middle Aged
  • Neurophysins / blood
  • Osmolar Concentration
  • Polydipsia / blood
  • Polydipsia / diagnosis
  • Polydipsia, Psychogenic / blood
  • Polydipsia, Psychogenic / diagnosis*
  • Polyuria / blood
  • Polyuria / diagnosis*
  • Protein Precursors / blood
  • Retrospective Studies
  • Syndrome
  • Vasopressins / blood
  • Water Deprivation*
  • Young Adult

Substances

  • AVP protein, human
  • Neurophysins
  • Protein Precursors
  • Vasopressins